Gennao Bio is Biotechnology in United States that focus on platform technology business. Founded in 2020. They cover business area such as developer, target nucleic acid therapeutic, muscle disease, gene monoclonal antibody, (GMAB) platform technology, non-covalently bind, therapeutic level, nucleic acid payload, cell, patient, outcome.
2020
( 4 years old in 2024 )
Platform Technology
-
New York, NY
United States
Private
developertarget nucleic acid therapeuticmuscle diseasegene monoclonal antibody(GMAB) platform technologynon-covalently bindtherapeutic levelnucleic acid payloadcellpatientoutcome
* We use standard office opening hours in near Gennao Bio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Gennao Bio is Biotechnology business from United States that founded in 2020 (4 years old in 2024), Gennao Bio business is focusing on Platform Technology.
Gennao Bio headquarter office and corporate office address is located in New York, NY United States.
Gennao Bio was founded in United States.
In 2024, Gennao Bio is currently focus on platform technology sector.
Above is snippet of Google Trends for "platform technology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Gennao Bio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
